Plasma endocannabinoid alterations in individuals with substance use disorder are dependent on the "mirror effect" of schizophrenia

Desfossés, Joëlle; Stip, Emmanuel; Bentaleb, Lahcen Ait; Lipp, Olivier; Chiasson, Jean-Pierre; Furtos, Alexandra; Venne, Karine; Kouassi, Edouard; Potvin, Stéphane; Rubio, Gabriel; Martinez, Diana
September 2012
Frontiers in Psychiatry;Sep2012, Vol. 3, p1
Academic Journal
No abstract available.


Related Articles

  • The endocannabinoid system as a target for modelling psychosis. Koethe, Dagmar; Hoyer, Carolin; Leweke, F. Markus // Psychopharmacology;Nov2009, Vol. 206 Issue 4, p551 

    Model psychosis is characterised by experimentally induced symptoms of withdrawal from reality, frequently accompanied by perceptual disturbances, thought disorders, delusional ideas and sometimes by hallucinations. These “altered states of consciousness” provide a long-standing and...

  • Endocannabinoids Regulate Growth and Survival of Human Eccrine Sweat Gland-Derived Epithelial Cells. Czifra, Gabriella; Szöllősi, Attila G; Tóth, Balázs I; Demaude, Julien; Bouez, Charbel; Breton, Lionel; Bíró, Tamás // Journal of Investigative Dermatology;Aug2012, Vol. 132 Issue 8, p1967 

    The functional existence of the emerging endocannabinoid system (ECS), one of the new neuroendocrine players in cutaneous biology, is recently described in the human skin. In this study, using human eccrine sweat gland-derived immortalized NCL-SG3 model cells and a wide array of cellular and...

  • Substance Misuse in Patients with Schizophrenia: Epidemiology and Management. Kavanagh, D.J.; McGrath, J.; Saunders, J.B.; Dore, G.; Clark, D. // Drugs;2002, Vol. 62 Issue 5, p743 

    Substance misuse in individuals with schizophrenia is very common, especially in young men, in communities where use is frequent and in people receiving inpatient treatment. Problematic use occurs at very low intake levels, so that most affected people are not physically dependent (with the...

  • Cannabis-Induced Bipolar Disorder with Psychotic Features: A Case Report. Khan, Masood A.; Akella, Sailaja // Psychiatry (1550-5952);Dec2009, Vol. 6 Issue 12, p44 

    There has been considerable debate regarding the causal relationship between chronic cannabis abuse and psychiatric disorders. Clinicians agree that cannabis use can cause acute adverse mental effects that mimic psychiatric disorders, such as schizophrenia and bipolar disorder. Although there is...

  • The Endocannabinoid System and Schizophrenia: Integration of Evidence. Zamberletti, Erica; Rubino, Tiziana; Parolaro, Daniela // Current Pharmaceutical Design;Nov2012, Vol. 18 Issue 32, p4980 

    Cannabis derivatives produce their CNS effect through activation of the endocannabinoid system, a recently discovered signalling system comprising specific receptors, their intrinsic lipid ligands and the associated enzymatic machinery (transporters, biosynthetic and degradative enzymes). This...

  • The Endocannabinoid System in Peripheral Lymphocytes as a Mirror of Neuroinflammatory Diseases. Centonze, Diego; Battistini, Luca; Maccarrone, Mauro // Current Pharmaceutical Design;Aug2008, Vol. 14 Issue 23, p2370 

    During immuno-mediated attack of the brain, activation of endocannabinoids represents a protective mechanism, aimed at reducing both neurodegenerative and inflammatory damage through various and partially converging mechanisms that involve neuronal and immune cells. Here, we review the main...

  • Effects of Psychoactive Substances in Schizophrenia - Findings of Structural and Functional Neuroimaging. Walter, M.; Denier, N.; Vogel, M.; Lang, U. E. // Current Topics in Medicinal Chemistry;Nov2012, Vol. 12 Issue 21, p2426 

    Schizophrenia is a major mental illness that is characterized by psychosis, social withdrawal, and cognitive impairment. High comorbidity rates with substance use disorders have consistently been found - especially with abuse of cannabis and psychostimulants. While the role of these drugs in the...

  • Sistema endocannabinoide y polimorfismos del gen CNR1 en la esquizofrenia y los trastornos adictivos. Martínez-Gras, I.; Hoecnika, J.; Pérez-Hernández, E.; Rodríguez-Jiménez, R.; Ponce, G.; Jiménez-Arriero, M. A.; Ramos-Atance, J.; Palomo, T.; Rubio, G. // Actas Espanolas de Psiquiatria;mar2007, Vol. 35 Issue 2, p122 

    Substance abuse is the most prevalent comorbid psychiatric condition associated with schizophrenia. Cannabis is a drug frequently used for schizoprenic patients. In the last decades the endocannabinoid system and their endogenous ligands have been discovered. Endogenous cannabinoids act in the...

  • Alkol/Madde Bağımlılarında Ketiapinin Etkisi ve Kötüye Kullanımı: Olgu Serisi ve Gözden Geçirme. Evren, Cüneyt; Karatepe, Hasan Turan; Aydın, Agah; Dalbudak, Ercan; Cakmak, Duran // Klinik Psikofarmakoloji Bulteni;Jun2009, Vol. 19 Issue 2, p148 

    Quetiapine is an atypical antipsychotic drug, which has been found to be effective in the treatment of schizophrenia, bipolar disorder, and related disorders. Recent studies report the effectiveness of quetiapine among patients with substance use disorders both as a single disorder and as a...

  • Substance Use Among Patients with Schizophrenia in a University Hospital. Akvardar, Yildiz; Tumuklu, Mevhibe; Akdede, Berna Binnur; Ulas, Halls; Kitis, Arzu; Alptekin, Koksal // Klinik Psikofarmakoloji Bulteni;Dec2004, Vol. 14 Issue 4, p191 

    Substance use among patients with schizophrenia in a university hospital Objective: Individuals with schizoprenia are known to be at increased risk for comorbid substance use disorders compared to the general population. The aim of the study was to identify the prevalence of substance use and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics